Naproxcinod
CAS No. | 163133-43-5 | Cat. No. | BCP08710 |
Name | Naproxcinod | ||
Synonyms | Naproxen-N-butyl nitrate; Nitronaproxen; AZD 3582; AZD-3582; AZD3582; HCT3012; HCT-3012; HCT 3012; AR-P-900758XX; NO-naproxen; | ||
Formula | C18H21NO6 | M. Wt | 347.36 |
Description | Naproxcinod is a nitric oxide-releasing NSAID derivative. Naproxcinod significantly ameliorated skeletal muscle force and resistance to fatigue in sedentary as well as in exercised mice, reduced inflammatory infiltrates and fibrosis deposition in both cardiac and diaphragm muscles. Conversely, the equimolar dose of naproxen showed no effects on fibrosis and improved muscle function only in sedentary mice. In addition to anti-inflammatory activity, naproxcinod as a promising candidate for treatment of Duchenne Muscular Dystrophy. | ||
Pathways | Neuro Signaling Pathway | ||
Targets | COX |
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.